Navigation Links
hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate

ProductshKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
Company Upstate
Item hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line
Price 
Description PrecisION Ion Channel Cell Lines
High Quality, Functionally-Validated, Ion Channel Cell Lines

Ion channels are well known for having a critical role in nerve and muscle function and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression.

Historically, ion channels have been under exploited as drug targets primarily due to the lack of functional high throughput screening technologies. Over recent years, there has been considerable progress in this important area. However, now there is a requirement for high quality research tools that will allow the full benefit of the new screening technologies to be realised. Upstate has built a portfolio of ion channel cell lines to meet these new and evolving needs in the drug discovery industry.

Our ion channel cell lines are available off of the shelf. These cell lines are fully validated using electrophysiology, stable (>25 passage) and licensed for drug discovery research. The objective is to provide the pharmaceutical industry with a range of ion channel cell lines to support drug discovery, lead optimisation and safety pharmacology functions.
Info UpstateUpstate
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500 or 951-676-8080
Tech Support: 800 548-7853
Fax Number: 800-437-7502 or 951-676-9209
Web Site: http://www.upstate.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
2. Recombinant RNasin® Ribonuclease Inhibitor from Promega
3. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
4. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
5. hERG-CHO K1 Recombinant Cell Line from Upstate
6. hERG-CHO K1 Recombinant Cell Line from Upstate
7. hHCN4-CHO K1 Recombinant Cell Line from Upstate
8. hKv1.5-CHO K1 Recombinant Cell Line from Upstate
9. hNav1.6-HEK293 Recombinant Cell Line from Upstate
10. hKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate
11. Smac/DIABLO, Human, Recombinant, E. coli from Calbiochem
... Quality 96 Well BAC Prep; ... preparation from 1.5ml 2xYT cultures; ... automated fluorescent sequencing for small ... ProPrep strategy which minimizes shearing ...
... monoclonal [SPM278] to 67kD Laminin Receptor, prediluted ... N592 live cells (Human). Reactivity / ... tested in other species. Background Information ... of basement membrane, displays multiple biological activities ...
Mouse Anti-Lamin B...
TLN2 Antibody...
Biology Products:
(Date:8/7/2018)... ... August 07, 2018 , ... Nanomedical ... announces a new publication titled, “Synthetic Molecules for Disruption of the Myc ... prominently features use of Agile R100, described as a “ field-effect transistor (Bio-FET) ...
(Date:8/1/2018)... ... , ... Dr. Asher Kimchi, Founder and Chairman of the International Academy ... at the 23rd World Congress on Heart Disease held in Boston, MA, USA. In ... Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Chairman Dr. John A. Elefteriades, ...
(Date:7/31/2018)... ... July 31, 2018 , ... ACEA Biosciences, is a privately owned biotechnology company ... introduced the xCELLigence RTCA S16, which the ideal entry level model for exploratory studies ... S16can be placed in any standard CO2 tissue culture incubator. The user friendly ...
Breaking Biology News(10 mins):
(Date:8/14/2018)... ... August 14, 2018 , ... ... at the 11th Congress of the Chinese Association of Orthopaedic Surgeons (CAOS) held ... Fule Science & Technology Development , Beijing, and Invibio Biomaterial Solutions ...
(Date:8/9/2018)... ... August 08, 2018 , ... ActX introduces GenoACT(sm), a Genetic ... by a talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians ... on the medical impact of a patient’s genetic variants , 2. Educational information ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... management (RCM), patient engagement and analytics software and services for physician practices, announced ... in its twenty-year history. After back-to-back record quarters in Q2 and Q3 last ...
(Date:8/7/2018)... (PRWEB) , ... August 06, 2018 , ... ... sciences and diagnostics companies, announces the placement of Dr. Paul Harney as President, ... Prescient’s North America growth strategy and enhancing client satisfaction. He was also named ...
Breaking Biology Technology: